Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial

Author: Kattan Michael W.  

Publisher: Adis International

ISSN: 1175-5652

Source: Applied Health Economics and Health Policy, Vol.9, Iss.5, 2011-09, pp. : 305-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content